BiferaRx (Alaven Pharmaceutical LLC)


Welcome to the PulseAid listing for the BiferaRx drug offered from Alaven Pharmaceutical LLC. This Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alaven Pharmaceutical LLC
NON-PROPRIETARY NAME: FOLIC ACID, Heme Iron Polypeptide, IRON DEXTRAN, and CYANOCOBALAMIN
SUBSTANCE NAME: FOLIC ACID; HEME IRON POLYPEPTIDE; IRON DEXTRAN; CYANOCOBALAMIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2010-05-01
END MARKETING DATE: 0000-00-00


BiferaRx HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBiferaRx from Alaven Pharmaceutical LLC
LABELER NAME: Alaven Pharmaceutical LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1; 6; 22; 25(mg/1; mg/1; mg/1; ug/1)
START MARKETING DATE: 2010-05-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68220-085_ff690efc-acac-4103-98ad-3a1613dc5573
PRODUCT NDC: 68220-085
APPLICATION NUMBER:

Other FOLIC ACID; HEME IRON POLYPEPTIDE; IRON DEXTRAN; CYANOCOBALAMIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alaven Pharmaceutical LLCBiferaRx